PL2252628T3 - Koniugaty antagonistów peptydowych analogu bombezyny - Google Patents

Koniugaty antagonistów peptydowych analogu bombezyny

Info

Publication number: PL2252628T3
Authority: PL; Poland
Prior art keywords: bombezin; peptide antagonists; analog peptide; analog; antagonists
Prior art date: 2008-03-07

Application number

PL09717301T

Other languages

English (en)

Inventor

Helmut Maecke

Jean Claude Reubi

Rosalba Mansi

Original Assignee

Universitätsspital Basel

Universität Bern

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-07

Filing date

2009-02-27

Publication date

2017-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39677415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2252628(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-02-27 Application filed by Universitätsspital Basel, Universität Bern filed Critical Universitätsspital Basel

2017-07-31 Publication of PL2252628T3 publication Critical patent/PL2252628T3/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL09717301T 2008-03-07 2009-02-27 Koniugaty antagonistów peptydowych analogu bombezyny PL2252628T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08075180A EP2100900A1 (en)	2008-03-07	2008-03-07	Bombesin analog peptide antagonist conjugates
EP09717301.7A EP2252628B1 (en)	2008-03-07	2009-02-27	Bombesin analog peptide antagonist conjugates

Publications (1)

Publication Number	Publication Date
PL2252628T3 true PL2252628T3 (pl)	2017-07-31

Family

ID=39677415

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09717301T PL2252628T3 (pl)	2008-03-07	2009-02-27	Koniugaty antagonistów peptydowych analogu bombezyny

Country Status (33)

Country	Link
US (2)	US9035023B2 (pl)
EP (2)	EP2100900A1 (pl)
JP (1)	JP5784911B2 (pl)
KR (2)	KR101734553B1 (pl)
CN (1)	CN101965358B (pl)
AR (1)	AR070809A1 (pl)
AU (1)	AU2009221204C1 (pl)
BR (1)	BRPI0909823B1 (pl)
CA (1)	CA2717427C (pl)
CL (1)	CL2009000537A1 (pl)
CO (1)	CO6290707A2 (pl)
CR (1)	CR11671A (pl)
CY (1)	CY1118687T1 (pl)
DK (1)	DK2252628T3 (pl)
DO (1)	DOP2010000269A (pl)
EC (1)	ECSP10010467A (pl)
ES (1)	ES2615805T3 (pl)
HU (1)	HUE032980T2 (pl)
IL (1)	IL207264A (pl)
MX (1)	MX2010009843A (pl)
NZ (1)	NZ587795A (pl)
PA (1)	PA8818501A1 (pl)
PE (1)	PE20091753A1 (pl)
PL (1)	PL2252628T3 (pl)
PT (1)	PT2252628T (pl)
RU (1)	RU2523531C2 (pl)
SI (1)	SI2252628T1 (pl)
SV (1)	SV2010003660A (pl)
TW (1)	TWI515011B (pl)
UA (1)	UA103314C2 (pl)
UY (1)	UY31693A (pl)
WO (1)	WO2009109332A1 (pl)
ZA (1)	ZA201006385B (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2380596A1 (en)	2010-04-20	2011-10-26	Technische Universität München	Cyclopentapeptide derivatives and uses thereof
EP2380597A1 (en)	2010-04-20	2011-10-26	Technische Universität München	Cyclopeptide derivatives and uses thereof
PH12013501018A1 (en) *	2010-11-22	2017-08-23	Piramal Imaging Sa	177lutetium-labeled bombesin analogs for radiotherapy
WO2012156511A1 (en) *	2011-05-19	2012-11-22	Universitätsspital Basel	Bombesin receptor targeting peptide incorporating a 1, 2, 3-triazole group in the backbone for preparing in vivo diagnostic and therapeutic agents
LT2900279T (lt)	2012-09-25	2019-11-11	Advanced Accelerator Applications Usa Inc	Grpr antagonistai, skirti grpr atžvilgiu teigiamo vėžio nustatymui, diagnozavimui ir gydymui
EP2740726A1 (en)	2012-12-07	2014-06-11	3B Pharmaceuticals GmbH	Neurotensin receptor ligands
WO2014164988A1 (en) *	2013-03-13	2014-10-09	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications
WO2015119763A1 (en) *	2014-02-06	2015-08-13	Immunomedics, Inc.	Al-f-18-labeled, al-f-19-labeled and ga-68-labeled gastrin-releasing peptide receptor (grpr)-antagonists for imaging of prostate cancer
WO2015185162A1 (en)	2014-06-06	2015-12-10	Technische Universität München	Modified cyclopentapeptides and uses thereof
EP2954933A1 (en)	2014-06-10	2015-12-16	3B Pharmaceuticals GmbH	Conjugate comprising a neurotensin receptor ligand
EP2954934A1 (en)	2014-06-11	2015-12-16	3B Pharmaceuticals GmbH	Conjugate comprising a neurotensin receptor ligand and use thereof
AU2015273934B2 (en)	2014-06-10	2020-08-20	3B Pharmaceuticals Gmbh	Conjugate comprising a neurotensin receptor ligand and use thereof
CN106794228B (zh)	2014-06-16	2021-09-03	科德克希思公司	用于治疗麸质不耐受和由其引起的病症的组合物和方法
CN104610431B (zh) *	2014-11-26	2017-12-15	南京市第一医院	一种多肽及其应用
JP2019504011A (ja)	2015-12-16	2019-02-14	ネプエトゥクス，エルエルシー	グルテン不耐症およびそれにより発生する障害を治療するための組成物および方法
EP3279197A1 (en)	2016-08-03	2018-02-07	Friedrich-Alexander-Universität Erlangen-Nürnberg	Diagnosis, treatment and prevention of neurotensin receptor-related conditions
US11241511B2 (en)	2016-12-29	2022-02-08	The General Hospital Corporation	HER3 peptides for imaging and radiotherapy
SI3568205T1 (sl)	2017-01-12	2023-12-29	Radiomedix Inc.	Zdravljenje rakastih celic, ki prekomerno izražajo receptorje za somatostatin, z uporabo derivatov okreotida, kelatiranih v radioizotope
MA49398A (fr) *	2017-05-05	2020-04-22	Eric Steven Burak	Anticorps monoclonaux anti-igf-1r et utilisations de ceux-ci
RU2681318C1 (ru) *	2017-11-24	2019-03-06	Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН)	Способ получения иммуносупрессорного пептида Abu-TGIRIS-Abu, меченного ионом Gd3+
AU2019469641B2 (en) *	2018-11-13	2025-04-03	Provincial Health Services Authority	Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders
EP3997104A1 (en)	2019-07-08	2022-05-18	3B Pharmaceuticals GmbH	Compounds comprising a fibroblast activation protein ligand and use thereof
EP3763726A1 (en)	2019-07-08	2021-01-13	3B Pharmaceuticals GmbH	Compounds comprising a fibroblast activation protein ligand and use thereof
WO2021121734A1 (en) *	2019-12-19	2021-06-24	Technische Universität München	Modified grpr antagonist peptides for imaging and therapy of cancer
WO2021250240A1 (en)	2020-06-12	2021-12-16	Orano	Diaza-18-crown-6 derivative useful for chelating radium, conjugate and radium chelate comprising the same, and uses thereof
EP3973999A1 (en) *	2020-09-28	2022-03-30	Orano Med	Conjugate or its salt comprising a gastrin-releasing peptide receptor antagonist and uses thereof
WO2022123462A1 (en)	2020-12-09	2022-06-16	3B Pharmaceuticals Gmbh	Radiolabelled prostate specific membrane antigen (psma) inhibitors and use thereof
EP4050018A1 (en)	2021-01-07	2022-08-31	3B Pharmaceuticals GmbH	Compounds comprising a fibroblast activation protein ligand and use thereof
AU2022262350B2 (en)	2021-04-20	2026-05-07	Terrapower Isotopes, Llc	Titania based generators for ac-225 generation
KR20240133798A (ko)	2021-12-17	2024-09-04	쓰리비 파마슈티컬스 게엠베하	탄산 무수화효소 ix 리간드
EP4499663A1 (en)	2022-03-25	2025-02-05	Provincial Health Services Authority	Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders
CN119923279A (zh)	2022-09-07	2025-05-02	3B制药有限公司	前列腺特异性膜抗原(psma)配体及其用途
CN117919452B (zh) *	2023-03-09	2026-05-12	中国科学院宁波材料技术与工程研究所	一种亚细胞器主动靶向成像探针及其制备方法
WO2024212808A1 (zh) *	2023-04-10	2024-10-17	湖南中晟全肽生物科技股份有限公司	蛙皮素类多肽化合物及其用途
EP4455159A1 (en)	2023-04-25	2024-10-30	3B Pharmaceuticals GmbH	Gastric inhibitory peptide receptor ligands with bio-distribution modifier
WO2025054727A1 (en) *	2023-09-13	2025-03-20	Provincial Health Services Authority	Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders
CN120019818A (zh) *	2023-11-20	2025-05-20	湖南中晟全肽生物科技股份有限公司	一种多肽偶联药物及其制备方法和用途
WO2025109003A1 (en)	2023-11-21	2025-05-30	3B Pharmaceuticals Gmbh	P-cadherin ligands
WO2025119203A1 (zh) *	2023-12-05	2025-06-12	烟台蓝纳成生物技术有限公司	一种异二聚体放射性核素偶联药物、制备及其应用
WO2025217074A1 (en) *	2024-04-08	2025-10-16	Radionetics Oncology, Inc.	Kisspeptin receptor (kiss1r) targeted therapeutics and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4885363A (en)	1987-04-24	1989-12-05	E. R. Squibb & Sons, Inc.	1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5021556A (en)	1987-07-22	1991-06-04	Neorx Corporation	Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
US5075099A (en)	1988-05-31	1991-12-24	Neorx Corporation	Metal radionuclide chelating compounds for improved chelation kinetics
US5364613A (en)	1989-04-07	1994-11-15	Sieving Paul F	Polychelants containing macrocyclic chelant moieties
DE69018226T2 (de) *	1989-07-20	1995-09-21	Sandoz-Patent-Gmbh, 79539 Loerrach	Markierte polypeptidderivate.
US5686410A (en) *	1989-07-20	1997-11-11	Novartis Ag	Polypeptide derivatives
US5367080A (en)	1990-11-08	1994-11-22	Sterling Winthrop Inc.	Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
US5369094A (en)	1990-11-29	1994-11-29	The Administrators Of The Tulane Educational Fund	Polypeptide bombesin antagonists
US5965107A (en)	1992-03-13	1999-10-12	Diatide, Inc.	Technetium-99m labeled peptides for imaging
US7060247B2 (en)	1997-04-22	2006-06-13	The Curators Of The University Of Missouri	Gastrin receptor-avid peptide conjugates
EP0977579B1 (en)	1997-04-22	2009-03-11	Curator Of The University Of Missouri	Gastrin receptor-avid peptide conjugates
US5886142A (en)	1997-05-20	1999-03-23	Thomas Jefferson University	Radiolabeled thrombus imaging agents
US6436989B1 (en)	1997-12-24	2002-08-20	Vertex Pharmaceuticals, Incorporated	Prodrugs of aspartyl protease inhibitors
BR9814484A (pt)	1997-12-24	2000-10-10	Vertex Pharma	"pró-drogas de inibidores de aspartil protease"
WO1999033795A1 (en)	1997-12-24	1999-07-08	Vertex Pharmaceuticals Incorporated	Prodrugs of aspartyl protease inhibitors
WO1999033792A2 (en)	1997-12-24	1999-07-08	Vertex Pharmaceuticals Incorporated	Prodrugs os aspartyl protease inhibitors
GR1003661B (el) *	2000-05-25	2001-09-05	Εθνικο Κεντρο Ερευνας Φυσικων Επιστημων (Εκεφε) "Δημοκριτος"...	ΣΥΝΘΕΣΗ, ΒΙΟΛΟΓΙΚΗ ΚΑΙ ΠΡΟΚΛΙΝΙΚΗ ΑΞΙΟΛΟΓΗΣΗ ΑΝΑΛΟΓΩΝ ΤΗΣ (D-Phe6, Leu-NHEt13, des-Met14)-ΒΟΜΒΕΣΙΝΗΣ (6-14)ΤΡΟΠΟΠΟΙΗΜΕΝΩΝ ΜΕ ΠΑ ΡΑΓΩΓΑ ΤΟΥ 1,4,8,11-ΤΕΤΡΑΑΖΑΕΝΔΕΚΑΝΙΟΥ(1,4,8,11-TETRAAZAUNDECAN E)ΚΑΙ ΕΠΙΣΗΜΑΣΜΕΝΩΝ ΜΕ ΤΕΧΝΗΤΙΟ-99M- ΓΙΑ ΕΦΑΡΜΟΓΗ ΣΤΗΝ ΟΓΚΟΛΟΓ
BR0017393A (pt) *	2000-12-20	2004-02-03	Warner Lambert Co	Usos de antagonistas de receptor de bombesina não-peptìdicos para o tratamento da ansiedade e distúrbios do pânico
US7226577B2 (en)	2003-01-13	2007-06-05	Bracco Imaging, S. P. A.	Gastrin releasing peptide compounds
US20080008649A1 (en)	2003-01-13	2008-01-10	Bracco Imaging S.P.A.	Gastrin Releasing Peptide Compounds
US7850947B2 (en)	2003-01-13	2010-12-14	Bracco Imaging S.P.A.	Gastrin releasing peptide compounds
US7922998B2 (en) *	2003-01-13	2011-04-12	Bracco Imaging S.P.A.	Gastrin releasing peptide compounds
SG177216A1 (en) *	2003-07-24	2012-01-30	Bracco Imaging Spa	Stable radiopharmaceutical compositions and methods for their preparation
US20090062509A1 (en)	2006-03-16	2009-03-05	Aldo Cagnolini	Chelation of metals to thiol groups using in situ reduction of disulfide-containing compounds by phosphines
PH12013501018A1 (en) *	2010-11-22	2017-08-23	Piramal Imaging Sa	177lutetium-labeled bombesin analogs for radiotherapy

2008
- 2008-03-07 EP EP08075180A patent/EP2100900A1/en not_active Withdrawn
2009
- 2009-02-27 UA UAA201011560A patent/UA103314C2/ru unknown
- 2009-02-27 EP EP09717301.7A patent/EP2252628B1/en active Active
- 2009-02-27 CA CA2717427A patent/CA2717427C/en active Active
- 2009-02-27 JP JP2010549043A patent/JP5784911B2/ja active Active
- 2009-02-27 WO PCT/EP2009/001403 patent/WO2009109332A1/en not_active Ceased
- 2009-02-27 DK DK09717301.7T patent/DK2252628T3/en active
- 2009-02-27 PT PT97173017T patent/PT2252628T/pt unknown
- 2009-02-27 ES ES09717301.7T patent/ES2615805T3/es active Active
- 2009-02-27 MX MX2010009843A patent/MX2010009843A/es not_active Application Discontinuation
- 2009-02-27 AU AU2009221204A patent/AU2009221204C1/en active Active
- 2009-02-27 CN CN200980107992.5A patent/CN101965358B/zh active Active
- 2009-02-27 US US12/921,209 patent/US9035023B2/en active Active
- 2009-02-27 SI SI200931607A patent/SI2252628T1/sl unknown
- 2009-02-27 KR KR1020107022308A patent/KR101734553B1/ko active Active
- 2009-02-27 PL PL09717301T patent/PL2252628T3/pl unknown
- 2009-02-27 HU HUE09717301A patent/HUE032980T2/en unknown
- 2009-02-27 RU RU2010140846/04A patent/RU2523531C2/ru active
- 2009-02-27 KR KR1020167029634A patent/KR20160128425A/ko not_active Withdrawn
- 2009-02-27 BR BRPI0909823-2A patent/BRPI0909823B1/pt active IP Right Grant
- 2009-02-27 NZ NZ587795A patent/NZ587795A/en unknown
- 2009-03-06 UY UY0001031693A patent/UY31693A/es not_active Application Discontinuation
- 2009-03-06 PA PA20098818501A patent/PA8818501A1/es unknown
- 2009-03-06 TW TW098107446A patent/TWI515011B/zh active
- 2009-03-06 CL CL2009000537A patent/CL2009000537A1/es unknown
- 2009-03-06 PE PE2009000339A patent/PE20091753A1/es not_active Application Discontinuation
- 2009-03-06 AR ARP090100799A patent/AR070809A1/es not_active Application Discontinuation
2010
- 2010-07-28 IL IL207264A patent/IL207264A/en active IP Right Grant
- 2010-09-06 ZA ZA2010/06385A patent/ZA201006385B/en unknown
- 2010-09-06 CO CO10110036A patent/CO6290707A2/es not_active Application Discontinuation
- 2010-09-07 CR CR11671A patent/CR11671A/es not_active Application Discontinuation
- 2010-09-07 EC EC2010010467A patent/ECSP10010467A/es unknown
- 2010-09-07 DO DO2010000269A patent/DOP2010000269A/es unknown
- 2010-09-07 SV SV2010003660A patent/SV2010003660A/es not_active Application Discontinuation
2015
- 2015-03-27 US US14/671,106 patent/US20150265733A1/en not_active Abandoned
2017
- 2017-02-07 CY CY20171100170T patent/CY1118687T1/el unknown

Also Published As

Publication number	Publication date
IL207264A0 (en)	2011-08-01
EP2252628A1 (en)	2010-11-24
AR070809A1 (es)	2010-05-05
BRPI0909823A2 (pt)	2019-03-06
TW200944239A (en)	2009-11-01
US20150265733A1 (en)	2015-09-24
PA8818501A1 (es)	2010-04-21
KR101734553B1 (ko)	2017-05-11
JP5784911B2 (ja)	2015-09-24
CY1118687T1 (el)	2017-07-12
UA103314C2 (ru)	2013-10-10
US20110097266A1 (en)	2011-04-28
PE20091753A1 (es)	2009-12-13
DK2252628T3 (en)	2017-02-06
AU2009221204A1 (en)	2009-09-11
DOP2010000269A (es)	2010-10-31
HUE032980T2 (en)	2017-11-28
US9035023B2 (en)	2015-05-19
SV2010003660A (es)	2011-02-17
BRPI0909823B1 (pt)	2022-04-19
SI2252628T1 (sl)	2017-05-31
CA2717427A1 (en)	2009-09-11
PT2252628T (pt)	2017-02-10
ZA201006385B (en)	2016-10-26
RU2010140846A (ru)	2012-04-20
AU2009221204C1 (en)	2016-12-08
KR20110014565A (ko)	2011-02-11
CL2009000537A1 (es)	2010-07-19
CA2717427C (en)	2016-02-23
NZ587795A (en)	2012-07-27
RU2523531C2 (ru)	2014-07-20
CN101965358B (zh)	2019-09-03
ECSP10010467A (es)	2010-10-30
AU2009221204B2 (en)	2013-09-05
WO2009109332A1 (en)	2009-09-11
EP2100900A1 (en)	2009-09-16
MX2010009843A (es)	2011-03-04
CN101965358A (zh)	2011-02-02
CR11671A (es)	2010-11-01
CO6290707A2 (es)	2011-06-20
KR20160128425A (ko)	2016-11-07
JP2011515338A (ja)	2011-05-19
UY31693A (es)	2010-01-05
EP2252628B1 (en)	2016-12-28
IL207264A (en)	2017-02-28
TWI515011B (zh)	2016-01-01
ES2615805T3 (es)	2017-06-08

Publication	Publication Date	Title
HUS2200025I1 (hu)	2022-06-28	C5AR antagonisták
NO2022016I1 (no)	2022-05-25	Anifrolumab
DK2160221T3 (da)	2011-09-19	Cykliske peptid-CXCR4-antagonister
DK2515928T3 (da)	2014-08-25	Oxyntomodulin peptidanalog
BRPI0911743A2 (pt)	2015-07-07	"peptídeo"
IL207264A0 (en)	2011-08-01	Bonbesin analog peptide antagonist conjugates
BRPI0908116A2 (pt)	2015-10-06	pulverizador
HRP20151108T1 (xx)	2015-11-20	Antagonisti nogo-receptora
HRP20151120T1 (xx)	2015-11-20	Polipeptid ace2
DK2171053T3 (da)	2014-07-28	Natriuretiske polypeptider
PL2465864T3 (pl)	2015-03-31	Szczepionki z peptydem pochodzącym z Eph4
DK3115370T3 (da)	2019-07-29	Biologisk aktive peptider
EP2321062A4 (en)	2014-10-29	Sprayer
BRPI1012728A2 (pt)	2016-04-05	uso de tripeptídeos
EP2437770A4 (en)	2013-11-06	ANTIMICROBIAL PEPTIDES
BRPI1010661A2 (pt)	2016-03-15	peptídeo
BRPI0910722A2 (pt)	2015-09-29	columbário
HRP20150195T1 (xx)	2015-06-05	Antibakterijski peptidi
BRPI0908008A2 (pt)	2015-08-18	Farmacóforo dual - pde4-antagonistas muscarínicos
BR112012005119A2 (pt)	2016-11-22	novos antagonistas de hepcidina etanodiaminas
EP2280988A4 (en)	2011-08-10	ANGIOGENIC PEPTIDE
IT1395137B1 (it)	2012-09-05	Nuovi peptidi antipatogeni
BRPI0907519A2 (pt)	2015-07-28	Antagonistas farmacoforos-pde4-muscarínicos duais
EP2252310A4 (en)	2011-09-07	HETEROCYCLIC PEPTIDE KETOAMIDE
EP2370100A4 (en)	2013-05-22	PEPTIDE AGENTS